FGF21 and metabolic dysfunction-associated steatotic liver disease: We further demonstrate that recombinant FGF21 ameliorates hepatic lipid and iron accumulation in this NAFLD/NASH model by downregulating the PCB-induced overexpression of hepatic LCN2.